Deutsche Bank
BBNX

Deutsche Bank’s Beta Bionics BBNX Stock Holding History

Deutsche Bank’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Buy
48,222
+4,521
+10% +$53.8K ﹤0.01% 2538
2026
Q1 		$438K Buy
43,701
+4,401
+11% +$65.1K ﹤0.01% 2643
2025
Q4 		$1.2M Buy
39,300
+1,296
+3% +$34.6K ﹤0.01% 2104
2025
Q3 		$755K Buy
38,004
+24,345
+178% +$428K ﹤0.01% 2330
2025
Q2 		$199K Buy
13,659
+1,580
+13% +$22.4K ﹤0.01% 2968
2025
Q1 		$148K Buy
+12,079
New +$225K ﹤0.01% 3078

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Deutsche Bank's BBNX Position: Q2 2026 in Review

Deutsche Bank increased its Beta Bionics (BBNX) stake by 10% in Q2 2026, buying an estimated $53.8K and bringing the position to 48,222 shares worth $756K. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

Deutsche Bank first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.2M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Deutsche Bank held 48,222 shares of Beta Bionics worth $756K as of Q2 2026.
  • Deutsche Bank bought 4,521 Beta Bionics shares in Q2 2026, an estimated $53.8K.
  • Beta Bionics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2538 holding.
  • Deutsche Bank first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Deutsche Bank's Beta Bionics position peaked at $1.2M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.